CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion

Clinical and Experimental Metastasis

Volumn 29, Issue 1, 2012, Pages 27-38

  Bretz, Niko ^a   Noske, Aurelia ^b   Keller, Sascha ^a   Erbe Hofmann, Natalie ^a   Schlange, Thomas ^c   Salnikov, Alexei V ^a   Moldenhauer, Gerd ^a   Kristiansen, Glen ^b   Altevogt, Peter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c BAYER PHARMA AG   (Germany)

Author keywords

c Src; CD24; Cell invasion; Lipid rafts

Indexed keywords

CD24 ANTIGEN; PLACENTA PROTEIN 5; PROTEIN KINASE P60; GLYCOPROTEIN; SMALL INTERFERING RNA; TISSUE-FACTOR-PATHWAY INHIBITOR 2;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; BREAST TUMOR; DNA MICROARRAY; FEMALE; FLOW CYTOMETRY; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; ONCOGENE SRC; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANTIGENS, CD24; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; GENES, SRC; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 84856002464     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-011-9426-4     Document Type: Article

References (58)

1. Kay R, Rosten PM, Humphries RK (1991) CD24, a signal transducer modulating B cell activation responses, is a very short peptide with a glycosyl phosphatidylinositol membrane anchor. J Immunol 147(4):1412-1416
2. Kay R, Takei F, Humphries RK (1990) Expression cloning of a cDNA encoding M1/69-J11d heat-stable antigens. J Immunol 145(6):1952-1959 (Pubitemid 20336768)
3. Wenger RH, Ayane M, Bose R et al (1991) The genes for a mouse hematopoietic differentiation marker called the heat-stable antigen. Eur J Immunol 21(4):1039-1046
4. Kristiansen G, Machado E, Bretz N et al (2010) Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis. Lab Invest 90(7):1102-1116
5. Sammar M, Aigner S, Hubbe M et al (1994) Heat-stable antigen (CD24) as ligand for mouse P-selectin. Int Immunol 6(7):1027-1036 (Pubitemid 24221414)
6. Aigner S, Sthoeger ZM, Fogel M et al (1997) CD24, a mucintype glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 89(9):3385-3395 (Pubitemid 27229826)
7. Friederichs J, Zeller Y, Hafezi-Moghadam A et al (2000) The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells. Cancer Res 60(23):6714-6722
8. Kristiansen G, Sammar M, Altevogt P (2004) Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 35(3):255-262 (Pubitemid 40585311)
9. Lo HW, Zhu H, Cao X et al (2009) A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion. Cancer Res 69(17):6790-6798
10. Cao X, Geradts J, Dewhirst MW et al (2011) Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells. Oncogene. doi:10.1038/onc.2011.219
11. Aigner S, Ramos CL, Hafezi-Moghadam A et al (1998) CD24 mediates rolling of breast carcinoma cells on P-selectin. Faseb J 12(12):1241-1251 (Pubitemid 28418954)
12. Ahmed MA, Jackson D, Seth R et al (2009) CD24 is upregulated in inflammatory bowel disease and stimulates cell motility and colony formation. Inflamm Bowel Dis 16(5):795-803
13. Hahne M, Wenger RH, Vestweber D et al (1994) The heat-stable antigen can alter very late antigen 4-mediated adhesion. J Exp Med 179(4):1391-1395 (Pubitemid 24091801)
14. Baumann P, Cremers N, Kroese F et al (2005) CD24 expression causes the acquisition ofmultiple cellular properties associated with tumor growth and metastasis. Cancer Res 65(23):10783-10793 (Pubitemid 41715227)
15. Senner V, Sturm A, Baur I et al (1999) CD24 promotes invasion of glioma cells in vivo. J Neuropathol Exp Neurol 58(8):795-802 (Pubitemid 29372834)
16. Sagiv E, Starr A, Rozovski U et al (2008) Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA. Cancer Res 68(8):2803-2812 (Pubitemid 351556279)
17. Smith SC, Oxford G, Wu Z et al (2006) The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer. Cancer Res 66(4): 1917-1922
18. Wang W, Wang X, Peng L et al (2010) CD24-dependent MAPK pathway activation is required for colorectal cancer cell proliferation. Cancer Sci 101(1):112-119
19. Overdevest JB, Thomas S, Kristiansen G et al (2011) CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization. Cancer Res 71(11):3802-3811
20. Fukushima T, Tezuka T, Shimomura T et al (2007) Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24. J Biol Chem 282(25):18634-18644 (Pubitemid 47100243)
21. Al-Hajj M, Wicha MS, Benito-Hernandez A et al (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100(7):3983-3988 (Pubitemid 36418143)
22. Woodward WA, Sulman EP (2008) Cancer stem cells: markers or biomarkers? Cancer Metastasis Rev 27(3):459-470
23. Schabath H, Runz S, Joumaa S et al (2006) CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells. J Cell Sci 119(Pt 2):314-325 (Pubitemid 43210700)
24. Runz S, Mierke CT, Joumaa S et al (2008) CD24 induces localization of beta1 integrin to lipid raft domains. Biochem Biophys Res Commun 365(1):35-41 (Pubitemid 350110573)
25. Varma R, Mayor S (1998) GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 394(6695):798-801 (Pubitemid 28391646)
26. Simons K, Gerl MJ (2010) Revitalizing membrane rafts: new tools and insights. Nat Rev Mol Cell Biol 11(10):688-699
27. Ilangumaran S, Arni S, van Echten-Deckert G et al (1999) Microdomain-dependent regulation of Lck and Fyn proteintyrosine kinases in T lymphocyte plasma membranes. Mol Biol Cell 10(4):891-905 (Pubitemid 29193719)
28. Zarn JA, Zimmermann SM, Pass MK et al (1996) Association of CD24 with the kinase c-fgr in a small cell lung cancer cell line and with the kinase lyn in an erythroleukemia cell line. Biochem Biophys Res Commun 225(2):384-391 (Pubitemid 26355612)
29. Sammar M, Gulbins E, Hilbert K et al (1997) Mouse CD24 as a signaling molecule for integrin-mediated cell binding: functional and physical association with src-kinases. Biochem Biophys Res Commun 234(2):330-334 (Pubitemid 27243902)
30. Stefanova I, Horejsi V, Ansotegui IJ et al (1991) GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254(5034):1016-1019 (Pubitemid 21917433)
31. Baumann P, Thiele W, Cremers N et al (2011) CD24 interacts with and promotes the activity of c-src within lipid rafts in breast cancer cells, thereby increasing integrin-dependent adhesion. Cell Mol Life Sci. doi:10.1007/s00018-011-0756-9
32. Konduri SD, Tasiou A, Chandrasekar N et al (2000) Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion. Clin Exp Metastasis 18(4):303-308 (Pubitemid 32579398)
33. Herman MP, Sukhova GK, Kisiel W et al (2001) Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J Clin Invest 107(9):1117-1126 (Pubitemid 32422908)
34. Konduri SD, Tasiou A, Chandrasekar N et al (2001) Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro. Int J Oncol 18(1):127-131
35. Konduri SD, Rao CN, Chandrasekar N et al (2001) A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion. Oncogene 20(47):6938-6945 (Pubitemid 33052183)
36. Gaud G, Iochmann S, Guillon-Munos A et al (2009) TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions. J Cell Mol Med. doi:10.1111/j.1582- 4934.2009.00989.x
37. Sierko E, Wojtukiewicz MZ, Kisiel W (2007) The role of tissue factor pathway inhibitor-2 in cancer biology. Semin Thromb Hemost 33(7):653-659 (Pubitemid 350157008)
38. Wolterink S, Moldenhauer G, Fogel M et al (2010) Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma. Cancer Res 70(6):2504-2515
39. Jackson D, Waibel R, Weber E et al (1992) CD24, a signaltransducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. Cancer Res 52(19):5264-5270
40. Riedle S, Kiefel H, Gast D et al (2009) Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity. Biochem J 420(3):391-402
41. Gast D, Riedle S, Issa Y et al (2008) The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies. Oncogene 27(9):1281-1289 (Pubitemid 351294696)
42. Runz S, Keller S, Rupp C et al (2007) Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and Ep-CAM. Gynecol Oncol 107(3):563-571 (Pubitemid 350160873)
43. Theurillat JP, Ingold F, Frei C et al (2007) NY-ESO-1 protein expression in primary breast carcinoma and metastases: correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration. Int J Cancer 120(11):2411-2417 (Pubitemid 46642128)
44. Kristiansen G, Rose M, Geisler C et al (2010) Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype. Br J Cancer 102(12):1736-1745
45. Iochmann S, Blechet C, Chabot V et al (2009) Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion. Clin Exp Metastasis 26(5):457-467
46. Zhou Q, Rammohan K, Lin S et al (2003) CD24 is a genetic modifier for risk and progression of multiple sclerosis. Proc Natl Acad Sci U S A 100(25):15041-15046 (Pubitemid 37518013)
47. Fang X, Zheng P, Tang J et al (2010) CD24: from A to Z. Cell Mol Immunol 7(2):100-103
48. Mierke CT, Bretz N, Altevogt P (2011) Contractile forces contribute to increased GPI-anchored receptor CD24 facilitated cancer cell invasion. J Biol Chem. doi:10.1074/jbc.M111.245183 (in press)
49. Taniuchi K, Nishimori I, Hollingsworth MA (2011) Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BP. Cancer Res 71(3):895-905
50. Kedersha N, Anderson P (2002) Stress granules: sites of mRNA triage that regulate mRNA stability and translatability. Biochem Soc Trans 30(Pt 6):963-969 (Pubitemid 36002389)
51. Zhou C, Cunningham L, Marcus AI et al (2006) Arl2 and Arl3 regulate different microtubule-dependent processes. Mol Biol Cell 17(5):2476-2487
52. Yeatman TJ (2004) A renaissance for SRC. Nat Rev Cancer 4(6):470-480 (Pubitemid 38745532)
53. Guarino M (2010) Src signaling in cancer invasion. J Cell Physiol 223(1):14-26
54. Hitosugi T, Sato M, Sasaki K et al (2007) Lipid raft specific knockdown of SRC family kinase activity inhibits cell adhesion and cell cycle progression of breast cancer cells. Cancer Res 67(17):8139-8148 (Pubitemid 47395149)
55. Koppikar P, Choi SH, Egloff AM et al (2008) Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma. Clin Cancer Res 14(13):4284-4291
56. Guo H, Lin Y, Zhang H et al (2007) Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells. BMC Mol Biol 8:110
57. Kast C, Wang M, Whiteway M (2003) The ERK/MAPK pathway regulates the activity of the human tissue factor pathway inhibitor-2 promoter. J Biol Chem 278(9):6787-6794 (Pubitemid 36800667)
58. Dauer DJ, Ferraro B, Song L et al (2005) Stat3 regulates genes common to both wound healing and cancer. Oncogene 24(21): 3397-3408 (Pubitemid 40756241)